Used in targeted cancer therapy, particularly for prostate cancer. Binds specifically to STEAP1, a protein overexpressed in prostate tumor cells, enabling selective delivery of cytotoxic agents or immune-mediated destruction of cancer cells. Investigated for use in antibody-drug conjugates (ADCs) to enhance treatment precision and reduce off-target effects. Also serves as a reference standard in development and testing of biosimilars and immunoassays.